Validated specialised analytical methods
Learn moreBespoke study setup and conduct
Learn moreYear-round flexible support for all our clients
Learn more
Scott Houlton is the CEO of MLM. He has over 25 years of leadership experience in the pharmaceutical services industry across the drug development, clinical trial, and commercial segments. He holds degrees in International Business and Finance from The Ohio State University. He joined MLM in February 2021.
Dr. Lisa K Jennings is the CSO of MLM and the Managing Director of US operations. She is internationally recognized for her thought leadership in hematology and has served on numerous industry advisory boards. Her expertise and successful career at the University of Tennessee Health Science Center led her to start CirQuest Labs, now MLM Memphis, in October of 2008. Dr. Jennings joined MLM in July of 2020.
Roger Gasper joined MLM as CFO in October 2020 and has an established track record in both private and public companies. Most recently Mr. Gasper served as CFO at MaSTherCell, a leading cell and gene therapy contract development and manufacturing partner. He holds a degree in commerce and engineering from Drexel University.
Our VP Sales and Marketing joined MLM in August 2020 to support the future growth of the company. She has a M.Sc. in environmental sciences (toxicology and health) from the Wageningen University in the Netherlands. She has worked since 1997 in Business Development roles of growing seniority in the clinical trials arena, in CROs and central laboratories.
Our Managing Director studied chemistry at the University of Technology in Aachen, and went on to hold a post-doc position in the Department of Physiology. Since 2003, he has been with MLM, bringing his expertise as well as his scientific knowledge to hundreds of clinical studies.